CASI PHARMACEUTICALS, INC. Stock Split Ratio
CASI PHARMACEUTICALS, INC. (CASIF) had Stock Split Ratio of 1000.00% as of 2022-06-01, per its 20-F filed 2025-03-31.
Financial Statements › Notes › Equity
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2025-03-31
- 2022-06-01: Stockholders' Equity Note, Stock Split, Conversion Ratio 1000.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2022-06-01 | 1000.00% 20-F · filed 2025-03-31 |